{"id":"https://openalex.org/W238344699","doi":null,"title":"Mixing Personalized Medicine and CER, One Specialty Pharmacy Plows New Ground.","display_name":"Mixing Personalized Medicine and CER, One Specialty Pharmacy Plows New Ground.","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W238344699","mag":"238344699","pmid":"https://pubmed.ncbi.nlm.nih.gov/22478800","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2816165"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2816165","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2816165","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnol Healthc","raw_type":"Text"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2816165","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"John Carroll","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John Carroll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.04467524,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"5","first_page":"49","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.08399999886751175,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.055399999022483826,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/personalized-medicine","display_name":"personalized medicine","score":0.9010000228881836},{"id":"https://openalex.org/keywords/comparative-effectiveness-research","display_name":"comparative effectiveness research","score":0.9380000233650208},{"id":"https://openalex.org/keywords/specialty-pharmacy","display_name":"specialty pharmacy","score":0.7889999747276306},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.8790000081062317},{"id":"https://openalex.org/keywords/prasugrel","display_name":"prasugrel","score":1.0},{"id":"https://openalex.org/keywords/cyp2c19-polymorphism","display_name":"CYP2C19 polymorphism","score":0.8159999847412109},{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.6679999828338623},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.6359999775886536},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.5619999766349792},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.4390000104904175},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.3190000057220459},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.4860000014305115},{"id":"https://openalex.org/keywords/cyp2c9-polymorphism","display_name":"CYP2C9 polymorphism","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.6817095875740051},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.6560247540473938},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6338313221931458},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6187635660171509},{"id":"https://openalex.org/C2777028646","wikidata":"https://www.wikidata.org/wiki/Q416232","display_name":"Prasugrel","level":4,"score":0.550052285194397},{"id":"https://openalex.org/C20387591","wikidata":"https://www.wikidata.org/wiki/Q930752","display_name":"Specialty","level":2,"score":0.47751158475875854},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4568342864513397},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.43469634652137756},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29818177223205566},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.17783498764038086},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.10131490230560303},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:2816165","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2816165","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnol Healthc","raw_type":"Text"},{"id":"pmid:22478800","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22478800","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology healthcare","raw_type":"Journal Article"},{"id":"mag:238344699","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22478800","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2816165","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2816165","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnol Healthc","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2068326185","https://openalex.org/W2085488024","https://openalex.org/W1591196400","https://openalex.org/W2969153484","https://openalex.org/W1995447987","https://openalex.org/W2602126461","https://openalex.org/W4243346787","https://openalex.org/W2189365400","https://openalex.org/W2147570776","https://openalex.org/W2809142394"],"abstract_inverted_index":{"For":[0],"the":[1,11,31,57,65,78,99,166,170,225,245,248,269,280,288,303,315,330,349,381,389,393,396,409],"past":[2],"18":[3],"months,":[4],"Felix":[5],"Frueh,":[6,23],"PhD,":[7],"has":[8,52,199],"been":[9,53],"overseeing":[10],"development":[12],"of":[13,68,101,123,169,179,215,224,247,268,322,356,384,395],"an":[14,89,204],"elaborate":[15],"\u2014":[16,19,148,152,294,298],"and":[17,34,41,46,88,131,174,272,299,362],"costly":[18],"scientific":[20],"research":[21],"initiative.":[22],"who":[24,340],"was":[25],"associate":[26],"director":[27],"for":[28,38,74,120,157,265,305,314,392],"genomics":[29],"at":[30,209],"U.S.":[32],"Food":[33],"Drug":[35,39],"Administration\u2019s":[36],"Center":[37],"Evaluation":[40],"Research":[42],"before":[43],"being":[44],"wooed":[45],"won":[47],"by":[48],"Medco":[49,83,159,201,271],"Health":[50],"Solutions,":[51],"steadily":[54],"ramping":[55],"up":[56],"PBM\u2019s":[58],"ambitious":[59],"personalized":[60,102],"medicine":[61],"R&D":[62,90,143],"organization,":[63],"using":[64],"full":[66],"weight":[67],"its":[69],"massive":[70],"database":[71,112],"to":[72,98,164,189,202,218,338],"press":[73],"new":[75],"insights":[76],"into":[77,142],"ways":[79],"that":[80,94,207,233,266,308,345],"drugs":[81,171,332],"work.":[82],"is":[84,137,234],"building":[85],"certified":[86],"laboratories":[87],"complex":[91],"in":[92,197,278,334,376],"Indiana":[93],"will":[95,160,327,353,372,387],"be":[96,260],"devoted":[97],"advancement":[100],"medicine.\r\n\r\n\u201cAs":[103],"you":[104],"know,":[105],"we":[106,125],"have":[107,127,229],"a":[108,150,153,186,211,222,230,235,255,275,335,342,366],"large":[109],"longitudinal":[110],"pharmacy":[111],"with":[113,244,283],"65":[114],"million":[115],"members,\u201d":[116],"Frueh":[117],"says.":[118],"\u201cAnd":[119],"20":[121],"percent":[122],"them,":[124],"also":[126],"clinical":[128],"outcomes":[129],"data":[130,304],"claims":[132],"data.\u201d\r\n\r\nFor":[133],"now,":[134],"Frueh\u2019s":[135],"team":[136],"taking":[138,227],"another":[139],"big":[140],"stride":[141],"territory.":[144],"They":[145],"are":[146],"conducting":[147],"without":[149,380],"partner":[151],"comparative":[154],"effectiveness":[155,246],"study":[156,206,326],"which":[158,193,242,371],"recruit":[161],"14,000":[162],"patients":[163,216,226,339],"examine":[165,328],"relative":[167],"efficacy":[168,313],"clopidogrel":[172,228,264],"(Plavix)":[173],"prasugrel":[175,180,306,379],"(Effient).\r\n\r\nThe":[176],"recent":[177],"arrival":[178],"from":[181],"Eli":[182],"Lilly/Daiichi":[183],"Sankyo":[184],"as":[185],"direct":[187],"competitor":[188],"Sanofi-Aventis/Bristol-Myers":[190],"Squibb\u2019s":[191],"clopidogrel,":[192,370],"earned":[194],"$4.9":[195],"billion":[196],"2008,":[198],"prompted":[200],"run":[203],"observational":[205,325],"looks":[208],"how":[210,329],"genetically":[212],"defined":[213],"group":[214],"responds":[217],"each":[219],"blood":[220],"thinner.\r\n\r\nRoughly":[221],"quarter":[223],"2C19":[231],"enzyme":[232],"less":[236],"active":[237],"metabolizer":[238],"than":[239,263],"most":[240],"enzymes,":[241],"interferes":[243],"therapy.":[249],"But":[250],"prasugrel,":[251],"because":[252],"it":[253,309,386],"tracks":[254],"different":[256],"drug":[257,350,391],"pathway,":[258],"can":[259],"more":[261],"effective":[262],"segment":[267],"market.":[270],"Aetna":[273],"went":[274],"long":[276],"way":[277],"highlighting":[279],"pathway":[281],"effect":[282],"their":[284],"earlier":[285],"work":[286],"on":[287],"interaction":[289],"between":[290],"proton":[291],"pump":[292],"inhibitors":[293],"popular":[295],"heartburn":[296],"medications":[297],"clopidogrel.\r\n\r\nIn":[300],"late-stage":[301,402],"trials,":[302],"demonstrated":[307],"had":[310],"greater":[311],"overall":[312],"entire":[316],"patient":[317],"population":[318,336],"but":[319],"higher":[320],"rates":[321,355],"bleeding.":[323],"Medco\u2019s":[324],"two":[331],"perform":[333],"restricted":[337],"share":[341],"common":[343],"biomarker":[344],"indicates":[346],"they":[347],"metabolize":[348],"normally.":[351],"Researchers":[352],"measure":[354],"cardiovascular":[357],"deaths,":[358],"nonfatal":[359,363],"heart":[360],"attacks,":[361],"strokes":[364],"over":[365],"six-month":[367],"period.":[368],"If":[369],"lose":[373],"patent":[374],"protection":[375],"2011,":[377],"outperforms":[378],"increased":[382],"risk":[383],"bleeding,":[385],"remain":[388],"preferred":[390],"majority":[394],"market":[397],"\u2014at":[398],"least":[399],"until":[400],"other":[401],"drugs,":[403],"like":[404],"AstraZeneca\u2019s":[405],"ticagrelor":[406],"(Brilinta),":[407],"hit":[408],"marketplace.":[410]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}